GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.

OTCPK:GBGPF - Post by User

GB Group Ord Shs > Mathematics ACB - CMED in your hands !!!

<< Previous

Bullboard Posts

Next >>

Comment by PROtradingon Jan 10, 2018 11:16am

67 Views

Post# 27323434

RE:RE:Mathematics ACB - CMED in your hands !!!

CMED DOES NOT WANT THE ACB STINK BID! And CMED will merge with HIP now that HIP is pulling it's own weight but we aren't paying a dummy clown premium!

The vote is NO on ACB's stink bid takeover and YES on HIP's mutual merge as per management agreed terms.

Get Aurora to come back with

thorgb1 wrote:

Planecatcher wrote: think long terms guys it all up to you !

if you have 1000 shares in Cmed @ 26.62 = 26 620$

If ACB and CMED merge

1000 shares x 4.52 = 4520 shares of ACB @ 13.63 = 61 607$

toghether our shares would sky rocket and be a real power house and give WEED a run for their money.

Let's become the leaders in this industry and the envie of others .

Don't listen to this troll liar. You are getting 1.7 shares of ACB, not the 4.5 he wants you to believe. The current offer is capped at $24 value for each share of CMED, period.